Conflicts in Research
The discussion highlights the troubling influence of pharmaceutical funding on research outcomes, particularly in studies like the UK Biobank. Concerns are raised about the rising cancer rates despite significant investments in research, questioning the effectiveness of cancer charities. Additionally, the potential risks associated with statins, including an increased likelihood of diabetes, are examined, revealing a complex web of biases in medical research.In this clip
From this podcast
Doc Malik
#235 - Malcolm Kendrick: Challenging the Cholesterol Myth, Medical Ethics, and Big Pharma
Related Questions